By Business/Source
Currency:CNY
2025/FY
Stock NameRevenueRatio
结构性心脏病介入治疗产品销售89.1M98.36%
consulting service1.49M1.64%
By Product
Currency:CNY
2025/FY
Stock NameRevenueRatio
结构性心脏病介入治疗产品销售89.1M98.36%
consulting service1.49M1.64%
By Country/Region
Currency:CNY
2025/FY
Stock NameRevenueRatio
China Mainland49M54.09%
Other countries / regions41.59M45.91%
